Anixa Biosciences Stock Alpha and Beta Analysis
| ANIX Stock | USD 3.31 0.01 0.30% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Anixa Biosciences. It also helps investors analyze the systematic and unsystematic risks associated with investing in Anixa Biosciences over a specified time horizon. Remember, high Anixa Biosciences' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Anixa Biosciences' market risk premium analysis include:
Beta 0.86 | Alpha (0.04) | Risk 4.27 | Sharpe Ratio 0.0291 | Expected Return 0.12 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Anixa |
Anixa Biosciences Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Anixa Biosciences market risk premium is the additional return an investor will receive from holding Anixa Biosciences long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Anixa Biosciences. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Anixa Biosciences' performance over market.| α | -0.04 | β | 0.86 |
Anixa Biosciences expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Anixa Biosciences' Buy-and-hold return. Our buy-and-hold chart shows how Anixa Biosciences performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Anixa Biosciences Market Price Analysis
Market price analysis indicators help investors to evaluate how Anixa Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Anixa Biosciences shares will generate the highest return on investment. By understating and applying Anixa Biosciences stock market price indicators, traders can identify Anixa Biosciences position entry and exit signals to maximize returns.
Anixa Biosciences Return and Market Media
The median price of Anixa Biosciences for the period between Sat, Aug 31, 2024 and Fri, Nov 29, 2024 is 3.21 with a coefficient of variation of 6.44. The daily time series for the period is distributed with a sample standard deviation of 0.21, arithmetic mean of 3.26, and mean deviation of 0.16. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Acquisition by Titterton Lewis H Jr of 21646 shares of Anixa Biosciences at 3.06 subject to Rule 16b-3 | 09/12/2024 |
2 | Anixa Biosciences Unveils Phase 2 Study Plan for Breast Cancer Vaccine | 09/24/2024 |
3 | Anixa Biosciences Appoints Suyasha Gupta as Senior Director of Clinical Development | 10/07/2024 |
4 | Disposition of 16000 shares by Titterton Lewis H Jr of Anixa Biosciences at 2.575 subject to Rule 16b-3 | 10/22/2024 |
5 | Anixa Biosciences and Cleveland Clinic to Present Additional Data from Phase 1 Study of Breast Cancer Vaccine at the th Society for Immunotherapy of Cancer Annu... | 10/28/2024 |
6 | Acquisition by Catelani Michael of 500000 shares of Anixa Biosciences subject to Rule 16b-3 | 10/30/2024 |
7 | Anixa Biosciences and Cleveland Clinic Present New Updated Positive Data from Phase 1 Study of Breast Cancer Vaccine at the th Society for Immunotherapy of Canc... | 11/08/2024 |
8 | Anixa stock rises as Bitcoin added to treasury - Seeking Alpha | 11/22/2024 |
About Anixa Biosciences Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Anixa or other stocks. Alpha measures the amount that position in Anixa Biosciences has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 (projected) | Dividend Yield | 2.3E-5 | 2.2E-5 | Price To Sales Ratio | 536.1 | 860.62 |
Anixa Biosciences Upcoming Company Events
As portrayed in its financial statements, the presentation of Anixa Biosciences' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Anixa Biosciences' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Anixa Biosciences' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Anixa Biosciences. Please utilize our Beneish M Score to check the likelihood of Anixa Biosciences' management manipulating its earnings.
| 21st of March 2024 Upcoming Quarterly Report | View | |
| 12th of June 2024 Next Financial Report | View | |
| 31st of January 2024 Next Fiscal Quarter End | View | |
| 21st of January 2025 Next Fiscal Year End | View | |
| 31st of October 2023 Last Quarter Report | View | |
| 31st of October 2023 Last Financial Announcement | View |
Build Portfolio with Anixa Biosciences
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Anixa Stock Analysis
When running Anixa Biosciences' price analysis, check to measure Anixa Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anixa Biosciences is operating at the current time. Most of Anixa Biosciences' value examination focuses on studying past and present price action to predict the probability of Anixa Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anixa Biosciences' price. Additionally, you may evaluate how the addition of Anixa Biosciences to your portfolios can decrease your overall portfolio volatility.